// App-Quantinova.ai

: COMPARISON OF ACHIEVING 2019 ESC/EAS VERSUS 2018 ACC/AHA LDL-C GOALS FOR PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A CARDIOVASCULAR RISK SIMULATION FROM THE DA VINCI STUDY

Researchers

Presenter

  • Kosh R. Ray

Principal Investigators

  • Sarah Bray

  • Alberico L. Catapano

  • Neil Poulter

  • Antonio J. Vallejo-Vaz

  • Julia Brandts

  • Guillermo Villa

Medical Centers

  • Amgen (Europe) GmbH, Zug, Switzerland

  • Imperial College, London, United Kingdom

Locations

  • Switzerland

  • United Kingdom

Companies

  • Amgen (Europe) GmbH

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved